Tralokinumab (Adbry, LEO Pharma) in AD: Reviewing New Data From the ECZTRA 3 and ECZTEND Trials With Dr. Andy Blauvelt
Andy Blauvelt, MD, MBA, reviews new five-year data highlighting the efficacy of tralokinumab (Adbry, LEO Pharma) in atopic dermatitis (AD).